Loading
Latest filing published 28 Aug 2026 for ACTINOGEN MEDICAL LIMITED, €6,376. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Dr Geoffrey Brooke discloses dealings in 2 companies, chiefly Actinogen Medical Limited and ACW. Between 24 June 2026 and 28 August 2026, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 1 purchase, €0 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 28 August 2026 with a transaction (€6,376) in Actinogen Medical Limited. The last purchase on record was published on 24 June 2026, which is 116 days ago. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations